In their JNCCN commentary, "Value in Oncology: It Is in the Eyes of the Beholder," Nabhan et al 1 This comparative analysis, performed by experts in the use of these scoring systems, demonstrated substantial correlation (Spearman correlation, 0.68) between the scales and highlighted the methodologic issues driving disparity that can be addressed to further improve concordance. 3 The current versions of the ASCO and ESMO value scales, when expertly applied, do have substantial but, as yet, imperfect agreement. Both ESMO and ASCO are committed to rigorous processes of validation in the ongoing development of their respective frameworks, and users can expect improvements as the scales are further refined.
Finally, we believe that these scales can make a substantial contribution to the public health discourse, rational patient care, research design, and physician education.
